ABSIX | SSGSX | ABSIX / SSGSX | |
Total Expense Ratio | 0.91 | 1.26 | 72% |
Annual Report Gross Expense Ratio | 0.91 | 1.26 | 72% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 2.004 | 0.689 | 291% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2000000 | 2500 | 80,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.34B | 5.52B | 42% |
Annual Yield % from dividends | 0.68 | 0.47 | 144% |
Returns for 1 year | -10.02 | -4.89 | 205% |
Returns for 3 years | 11.12 | 9.83 | 113% |
Returns for 5 years | 41.43 | 31.67 | 131% |
Returns for 10 years | 20.12 | 27.73 | 73% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRVPX | 19.03 | 0.22 | +1.17% |
Nuveen Mid Cap Value Premier | |||
SHISX | 59.62 | 0.58 | +0.98% |
BlackRock Health Sciences Opps Svc | |||
PGICX | 18.33 | 0.14 | +0.77% |
Virtus KAR Equity Income C | |||
ANVHX | 10.50 | 0.03 | +0.29% |
American Century Non-US Intrs Val I | |||
FSYKX | 11.17 | -0.10 | -0.89% |
Fidelity Advisor Sustainable EM Eq C |